Perampanel

Routes
Oral (PO)
Half-Life (t½)
PO: 4.4d
Formula
C23H15N3O
Molecular Weight
349.39 g/mol
PubChem CID
9924495
Aliases
Fycompa

Pharmacological Mechanism

Selective non-competitive AMPA glutamate receptor antagonist — first-in-class. Adjunct for partial-onset + primary generalized tonic-clonic seizures. Black-box for psychiatric / behavioral adverse effects (aggression, suicidality).

Half-Life & Elimination Curve (PO: 4.4d)

100%50%25%12.5%0%0h0×t½4.4d1×t½8.8d2×t½13.1d3×t½17.5d4×t½21.9d5×t½0×t½ (0h): 100% remaining (~0.1 mg/L)1×t½ (4.4d): 50% remaining (~50.2 µg/L)2×t½ (8.8d): 25% remaining (~25.1 µg/L)3×t½ (13.1d): 12.5% remaining (~12.6 µg/L)4×t½ (17.5d): 6.3% remaining (~6.28 µg/L)5×t½ (21.9d): 3.1% remaining (~3.14 µg/L)
Plasma (PO)t½ Decay (4.4d)
  • 0×t½0h100% (0.1 mg/L)
  • 1×t½4.4d50% (50.2 µg/L)
  • 2×t½8.8d25% (25.1 µg/L)
  • 3×t½13.1d12.5% (12.6 µg/L)
  • 4×t½17.5d6.3% (6.28 µg/L)
  • 5×t½21.9d3.1% (3.14 µg/L)
Elimination t½4.4d (PO)
Rate Constant (ke)0.0066 h⁻¹
Time to Peak (Tmax)5.05h
Est. Peak (Cmax)0.1 mg/L
Clearance (CL)0.508 L/h
97% Washout (5×t½)21.9d

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References